Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies

MS Treatments

Jahr

Publikationsjahr
2023

Autoren

Autorenliste der Publikation
Dayan CM, Lecumberri B, Muller I, Ganesananthan S, Hunter SF, Selmaj KW, Hartung HP, Havrdova EK, LaGanke CC, Ziemssen T, Van Wijmeersch B, Meuth SG, Margolin DH, Poole EM, Baker DP, Senior PA.

Verlag

Publisher-Information
Mult Scler J Exp Transl Clin. 2023 Jan 3;9(1):20552173221142741.

Link

Zur Publikation (externer Server)
https://doi.org/10.1177/20552173221142741

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
TreatmentsMSZ2023